Takeda Pharmaceutical

TAKNYSE Japan Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$55.139 B

$17.45 +2.53%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#13SanofiSNY$106.0B
#14Regeneron PharmaceuticalsREGN$80.8B
#15Takeda PharmaceuticalTAK$55.1B
#16Teva Pharmaceutical IndustriesTEVA$41.2B
#17BeOne MedicinesONC$39.6B

Where these numbers come from

Share counts and financials for Takeda Pharmaceutical are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.